• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Stories

Chagas patient story: Juan Bautista

Home > Stories

Chagas patient story: Juan Bautista

Juan Bautista
6 Jul 2015

Colombia

For Juan Bautista Corzo Veloza, a 53 year old, father of three,  life is not the same since that day in January 2013 when a stroke left him “dead for three days,” he says. He was changing a tire while performing his duty as a driver, a job to which he had dedicated himself after retiring from the National Police, when he began to feel a sharp pain in his chest along with a slow loss of consciousness.

Juan Bautista

A colleague took him to the Police Hospital, where Juan Bautista is entitled to be treated after many years of service in the institution. There he was initially prognosed with “sudden death”, but survived after numerous resuscitation attempts. The doctors’ suspicions that he might have Chagas disease got him transferred to the National Institute of Health-INS, which performs diagnostic tests and provides free treatment to those affected by the disease in the country. The result was positive.

Juan Bautista never presented any symptoms of the disease. Advanced heart disease is a late symptom in chronic patients, like himself: “If not for the heart attack, I wouldn’t even know that Chagas disease exists”, he said. Nothing is as it used to be: Before he was an active man, he worked hard. Today walking a few meters can cause fatigue, about 35% of his heart is totally damaged and he has a pacemaker since he suffered the stroke. Chagas has completely changed his life. “I do not have the same energy I used to” he says grimly.

Treatment was carried out with benznidazole, the first-line drug treatment, that lasts for 60 days, to eliminate the parasite from the blood. “This drug caused me many side affects: I had headaches, dizziness, weakness… but I endured it because it was for my own good and I was ready to do everything possible to kill that parasite.”

“You do not know how serious the disease is until you’ve suffered from it,” he explains. “When I knew I had it, I decided to fight to live on and I insisted that people know about Chagas so that they become conscious of it and can prevent it,” he adds.

Juan Bautista is grateful to the doctors and feels he had good quality treatment, but regrets that many other health institutions are limited in the diagnosis of “sudden death” without wondering what’s behind it.

  • Leia esta história em português
  • Lea esta historia en español

Images © Fetze Weerstra

Chagas disease

Read, watch, share

Loading...
Publications
2 Sep 2025

DNDi Brochure

News
28 Aug 2025

Luke Kanyang’areng becomes first Kenyan to receive Human Rights and Nursing Award

Doctor speaking with a woman and her child
Press releases
22 Aug 2025

DNDi receives Japan’s Hideyo Noguchi Africa Prize 2025 for its work to develop new treatments for neglected diseases in Africa 

Dr Luis Pizarro delivering his acceptance address at the Hideyo Noguchi Africa Prize ceremony on 22 August 2025
News
22 Aug 2025

Acceptance address, Dr Luis Pizarro – Fifth Hideyo Noguchi Africa Prize Ceremony

Statements
21 Aug 2025

DNDi’s briefing note for the 75th Session of the World Health Organization Regional Committee for Africa

News
12 Aug 2025

DNDi calls for nominations for private sector Board member 

News
8 Aug 2025

Statement from DNDi on Kenya’s elimination of rhodesiense sleeping sickness as a public health problem 

News
5 Aug 2025

ADB and DNDi sign MoU to advance healthcare cooperation on neglected diseases in Asia and the Pacific

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License